| 4.385 0.185 (4.4%) | 08-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.66 | 1-year : | 6.22 |
| Resists | First : | 4.84 | Second : | 5.32 |
| Pivot price | 4.24 |
|||
| Supports | First : | 4.07 | Second : | 3.38 |
| MAs | MA(5) : | 4.24 |
MA(20) : | 4.27 |
| MA(100) : | 4.7 |
MA(250) : | 4.56  |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 33 |
D(3) : | 27 |
| RSI | RSI(14): 48.1 |
|||
| 52-week | High : | 6.15 | Low : | 3.54 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ POCI ] has closed below upper band by 4.5%. Bollinger Bands are 62.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.53 - 4.55 | 4.55 - 4.57 |
| Low: | 4.18 - 4.2 | 4.2 - 4.22 |
| Close: | 4.35 - 4.38 | 4.38 - 4.41 |
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Thu, 13 Aug 2026
Precision Optics (POCI) CFO acquires 1,257 shares via stock compensation plan - Stock Titan
Mon, 10 Aug 2026
Precision Optics Corporation Inc (POCI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mon, 03 Aug 2026
POCI|Precision Optics Corporation Inc|Price:4.250|Chg%:+0.010 - TradingKey
Fri, 31 Jul 2026
Precision Optics Corporation, Inc. Revenue Breakdown – NASDAQ:POCI - TradingView
Wed, 13 May 2026
PRECISION OPTICS CORPORATION, INC. 3Q 2026: Revenue $8.71M, EPS $(0.01) — 10-Q Summary - TradingView
Wed, 13 May 2026
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 11 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 20.9 (%) |
| Held by Institutions | 44.4 (%) |
| Shares Short | 24 (K) |
| Shares Short P.Month | 12 (K) |
| EPS | -0.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.84 |
| Profit Margin | -17.1 % |
| Operating Margin | -0.8 % |
| Return on Assets (ttm) | -11.2 % |
| Return on Equity (ttm) | -29.7 % |
| Qtrly Rev. Growth | 108 % |
| Gross Profit (p.s.) | 0.36 |
| Sales Per Share | 2.64 |
| EBITDA (p.s.) | -0.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -6.86 |
| PEG Ratio | 0 |
| Price to Book value | 2.38 |
| Price to Sales | 1.65 |
| Price to Cash Flow | -32.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|